Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.
about
Targeting lung cancer through inhibition of checkpoint kinases.Cancer stem cell marker-expressing cell-rich spheroid fabrication from PANC-1 cells using alginate microcapsules with spherical cavities templated by gelatin microparticles.Synergism between bosutinib (SKI-606) and the Chk1 inhibitor (PF-00477736) in highly imatinib-resistant BCR/ABL⁺ leukemia cells.ATR/CHK1 inhibitors and cancer therapy.
P2860
Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@en
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@nl
type
label
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@en
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@nl
prefLabel
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@en
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@nl
P2093
P2860
P1476
Combined gemcitabine and CHK1 ...... ll cell lung cancer cell line.
@en
P2093
Alessandra Blasina
Douglas D Fang
Gerrit Los
Jianying Wang
Jill Kornmann
Jitesh P Jani
Justin Bingham
Konstantinos Tsaparikos
Maruja E Lira
P2860
P2888
P304
P356
10.1007/S11684-013-0270-6
P577
2013-07-02T00:00:00Z